Tools
Tools
Mandomando, Inacio, Mwenda, Jason M., Nakamura, Tomoka, de Gouveia, Linda, von Gottberg, Anne, Kwambana-Adams, Brenda, Antonio, Martin, Messa, Augusto, Litt, David, Seaton, Shila, Weldegebriel, Goitom Gebremedhin, Biey, Joseph Nsiari-Muzeyi and Serhan, Fatima (2023) 'Evaluation of Laboratories Supporting Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance in the World Health Organization African Region, through the Performance of Coordinated External Quality Assessment'. Tropical Medicine and Infectious Disease, Vol 8, Issue 8, e413.
|
Text
tropicalmed-08-00413-v2.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
(1) Background:
Laboratories supporting the invasive bacteria preventable disease (IB-VPD) network are expected to demonstrate the capacity to identify the main etiological agents of pediatric bacterial meningitis (PBM) (Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae) on Gram stains and in phenotypic identification. Individual reports of sentinel site (SSL), national (NL) and regional reference (RRL) laboratories participating in the World Health Organization (WHO)-coordinated external quality assessment, distributed by the United Kingdom National External Quality Assessment (EQA) Services (UK NEQAS) for Microbiology between 2014 and 2019 were analyzed.
(2) Methods:
The panels consisted of (1) unstained bacterial smears for Gram staining, (2) viable isolates for identification and serotyping/serogrouping (ST/SG) and (3) simulated cerebral spinal fluid (CSF) samples for species detection and ST/SG using polymerase chain reaction (PCR). SSLs and NLs tested for Gram staining and species identification (partial panel). RRLs, plus any SSLs and NLs (optionally) also analyzed the simulated CSF samples (full panel). The passing score was ≥75% for NLs and SSLs, and ≥90% for RRLs and NLs/SSLs testing the full panel.
(3) Results:
Overall, 63% (5/8) of the SSLs and NLs were able to correctly identify the targeted pathogens, in 2019; but there were challenges to identify Haemophilus influenzae either on Gram stains (35% of the labs failed 2014), or in culture. Individual performance showed inconsistent capacity, with only 39% (13/33) of the SSLs/NLs passing the EQA exercise throughout all surveys in which they participated. RRLs performed well over the study period, but one of the two failed to reach the minimal passing score in 2016 and 2018; while the SSLs/NLs that optionally tested the full panel scored between 75% and 90% (intermediate pass category).
(4) Conclusions:
We identified a need for implementing a robust quality management system for timely identification of the gaps and then implementing corrective and preventive actions, in addition to continuous refresher training in the SSLs and NLs supporting the IB-VPD surveillance in the World Health Organization, Regional Office for Africa (WHO AFRO).
| Item Type: | Article |
|---|---|
| Subjects: | QY Clinical Pathology > QY 25 Laboratory techniques and procedure WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 202 Pneumonia (General or not elsewhere classified) |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
| Digital Object Identifer (DOI): | https://doi.org/10.3390/tropicalmed8080413 |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | JISC Pubrouter |
| Date Deposited: | 31 Aug 2023 08:59 |
| Last Modified: | 31 Aug 2023 08:59 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/23025 |
Statistics
Actions (login required)
 |
Edit Item |